Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
39.47
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Kobayashi Pharmaceutical Shareholders Equity (Quarterly) : 1.290B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.290B |
| March 31, 2026 | 1.313B |
| December 31, 2025 | 1.346B |
| September 30, 2025 | 1.436B |
| June 30, 2025 | 1.442B |
| March 31, 2025 | 1.385B |
| December 31, 2024 | 1.358B |
| September 30, 2024 | 1.431B |
| June 30, 2024 | 1.304B |
| March 31, 2024 | 1.354B |
| December 31, 2023 | 1.453B |
| September 30, 2023 | 1.438B |
| June 30, 2023 | 1.443B |
| March 31, 2023 | 1.494B |
| December 31, 2022 | 1.500B |
| September 30, 2022 | 1.416B |
| June 30, 2022 | 1.468B |
| March 31, 2022 | 1.585B |
| December 31, 2021 | 1.699B |
| September 30, 2021 | 1.742B |
| June 30, 2021 | 1.717B |
| March 31, 2021 | 1.683B |
| December 31, 2020 | 1.768B |
| September 30, 2020 | 1.704B |
| June 30, 2020 | 1.624B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.579B |
| December 31, 2019 | 1.589B |
| September 30, 2019 | 1.547B |
| June 30, 2019 | 1.513B |
| March 31, 2019 | 1.497B |
| December 31, 2018 | 1.515B |
| September 30, 2018 | 1.453B |
| June 30, 2018 | 1.440B |
| March 31, 2018 | 1.448B |
| December 31, 2017 | 1.365B |
| September 30, 2017 | 1.310B |
| June 30, 2017 | 1.286B |
| March 31, 2017 | 1.290B |
| December 31, 2016 | 1.229B |
| September 30, 2016 | 1.402B |
| June 30, 2016 | 1.378B |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 1.164B |
| December 31, 2014 | 1.114B |
| September 30, 2014 | 1.167B |
| June 30, 2014 | 1.240B |
| March 31, 2014 | 1.233B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Medifast, Inc. | 196.38M |
| Integrated BioPharma, Inc. | 17.67M |
| Kao Corp. | 6.888B |
| Shiseido Co., Ltd. | 3.917B |
| Skinvisible, Inc. | -10.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.550B |
| Total Liabilities (Quarterly) | 259.58M |
| Debt to Equity Ratio | 0.0034 |
| Current Ratio | 3.279 |
| Net Debt Paydown Yield | 0.01% |